Critical Care Septic Shock in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: Outcomes, Prognostic Factors, and Clinical Implications from a Multicenter ICU Cohort MedXY Editorial Team Sep 2, 2026
Highlight
Septic shock is a leading cause of ICU admission among allo-HSCT recipients, with a 63% mortality at 90 days.
Higher SOFA scores, fungal infections, and neutropenia independently predict poorer 90-day survival after septic shock.
Early aminoglycoside therapy correlates with improved short-term survival, though its causal role remains uncertain.
Age, graft-versus-host disease type, and early bacterial documentation do not independently affect 90-day mortality.
Study Background and Disease Burden MedXY registered readers
Sign in free to continue reading Create or use your MedXY account to unlock the complete article.
Sign in / Register This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Like 0 Dislike 0 Favorite 0 Share 0 
